Prosecution Insights
Last updated: October 25, 2026

Clark+Elbing LLP - 10X Genomics, Inc.

Technology area: Chemistry & Materials

10 pending office actions • 1 client • 10 examiners • 7 art units • 0 of 10 (0%) have an AI response strategy ready

Analysis

Clark+Elbing LLP - 10X Genomics, Inc. is associated with Chemistry & Materials and has 9 pending office actions. The profile also records 9010 career applications, providing a broader prosecution context for the named client matter grouping.

The resolved allowance rate is 67.77%, and the average office actions per allowance is 3.89. These measures indicate the recorded historical outcome and the examination activity associated with allowance for the profile. Practitioners should use them as portfolio context while grounding decisions in the specific claims, references, and examiner positions for the matter at issue.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=9010 apps, methodology: how we score firms)

67.8%
Allowance Rate
n=9010
+0.63σ
Allowance Rate (norm)
n=9010
3.9
OAs to Allowance
n=3688
-0.04σ
OAs to Allow (norm)
n=3688
1175 days
Time to Allowance
n=3688
+28.5pp
Interview Lift
n=9010
27.7%
RCE Rate
n=9010
1.1%
Appeal Rate
n=9010

Rejection Performance (% of received rejections ultimately overcome)

75.8%
§101 Overcome
n=583
72.6%
§102 Overcome
n=1802
71.1%
§103 Overcome
n=2617
75.7%
§112 Overcome
n=2972

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
50%
Top-3 CPC Share
n=9010
5
Practitioners
n=9010
1802.0
Apps / Practitioner
n=9010

Portfolio Summary

10
Total Pending OAs
5
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (70%)
3
Medium (30%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (20%)
§102 only1 (10%)
Multi-statute (no §101)7 (70%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
90% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
10% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HUANG, RYAN 1 53.1% +31.1%
BORTOLI, JONATHAN 1 76.4% +40.2%
SIMMONS, VALERIE MICHELLE 1 27.7% +47.5%
MUI, CHRISTINE T 1 78.4% +19.8%
IMPINK, MOLLIE LLEWELLYN 1 55.6% +24.6%
NGUYEN, HENRY H 1 63.5% +36.7%
CHIU, MAY LEUNG 1 43.3% +26.1%
HYUN, PAUL SANG HWA 1 69.8% +36.3%
TURK, NEIL N 1 51.0% +44.2%
KASS, BENJAMIN JOSEPH 1 31.1% +64.4%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18132115 SYSTEMS WITH A GASKET AND METHODS FOR ANALYZING SAMPLES MUI, CHRISTINE T 118d overdue
18131223 BLISTER PACKS AND USES THEREOF IMPINK, MOLLIE LLEWELLYN 112d overdue
18177562 FLOW FOCUSING DEVICES, SYSTEMS, AND METHODS FOR HIGH THROUGHPUT DROPLET FORMATION CHIU, MAY LEUNG 19d overdue
18175885 DEVICES AND METHODS FOR FLOW CELL ASSEMBLY AND DISASSEMBLY HYUN, PAUL SANG HWA 26d
18606845 METHODS AND SYSTEMS INCLUDING FLOW AND MAGNETIC MODULES HUANG, RYAN —
18237268 METHOD FOR CONCENTRATING DROPLETS IN AN EMULSION SIMMONS, VALERIE MICHELLE —
18154516 DEVICES, SYSTEMS, AND METHODS FOR DIRECTING FLUID FLOW TURK, NEIL N —
18070887 FLOW CELLS AND METHODS OF USE THEREOF KASS, BENJAMIN JOSEPH —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18132115 SYSTEMS WITH A GASKET AND METHODS FOR ANALYZING SAMPLES MUI, CHRISTINE T 118d overdue
18131223 BLISTER PACKS AND USES THEREOF IMPINK, MOLLIE LLEWELLYN 112d overdue
18177562 FLOW FOCUSING DEVICES, SYSTEMS, AND METHODS FOR HIGH THROUGHPUT DROPLET FORMATION CHIU, MAY LEUNG 19d overdue
18177504 DEVICES, SYSTEMS, AND METHODS FOR HIGH THROUGHPUT DROPLET FORMATION NGUYEN, HENRY H 4d overdue
18175885 DEVICES AND METHODS FOR FLOW CELL ASSEMBLY AND DISASSEMBLY HYUN, PAUL SANG HWA 26d
18427317 DEVICES AND METHODS FOR GENERATING AND RECOVERING DROPLETS BORTOLI, JONATHAN 29d
18606845 METHODS AND SYSTEMS INCLUDING FLOW AND MAGNETIC MODULES HUANG, RYAN —
18237268 METHOD FOR CONCENTRATING DROPLETS IN AN EMULSION SIMMONS, VALERIE MICHELLE —

Client Portfolio (1 client)

Client (Assignee)Pending OAs
10x Genomics 10

Top Art Units

Art UnitApps
17583
17972
17771
37991
17961
17981
16821

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18606845 METHODS AND SYSTEMS INCLUDING FLOW AND MAGNETIC MODULES 10X Genomics, Inc. HUANG, RYAN 1777 §103§112 Non-Final OA — Pending Mar 15, 2024
18427317 DEVICES AND METHODS FOR GENERATING AND RECOVERING DROPLETS 10X Genomics, Inc. BORTOLI, JONATHAN 1797 §102 Non-Final OA 29d Pending Jan 30, 2024
18237268 METHOD FOR CONCENTRATING DROPLETS IN AN EMULSION 10X Genomics, Inc. SIMMONS, VALERIE MICHELLE 1758 §103 Final Rejection — Pending Aug 23, 2023
18132115 SYSTEMS WITH A GASKET AND METHODS FOR ANALYZING SAMPLES 10X Genomics, Inc. MUI, CHRISTINE T 1797 §102§103 Final Rejection 118d overdue Pending Apr 07, 2023
18131223 BLISTER PACKS AND USES THEREOF 10X Genomics, Inc. IMPINK, MOLLIE LLEWELLYN 3799 §103§112 Final Rejection 112d overdue Pending Apr 05, 2023
18177504 DEVICES, SYSTEMS, AND METHODS FOR HIGH THROUGHPUT DROPLET FORMATION 10X Genomics, Inc. NGUYEN, HENRY H 1758 §103 Final Rejection 4d overdue Pending Mar 02, 2023
18177562 FLOW FOCUSING DEVICES, SYSTEMS, AND METHODS FOR HIGH THROUGHPUT DROPLET FORMATION 10X Genomics, Inc. CHIU, MAY LEUNG 1758 §102§112 Final Rejection 19d overdue Pending Mar 02, 2023
18175885 DEVICES AND METHODS FOR FLOW CELL ASSEMBLY AND DISASSEMBLY 10X Genomics, Inc. HYUN, PAUL SANG HWA 1796 §102§103§112 Non-Final OA 26d Pending Feb 28, 2023
18154516 DEVICES, SYSTEMS, AND METHODS FOR DIRECTING FLUID FLOW 10X Genomics, Inc. TURK, NEIL N 1798 §102§112Other Non-Final OA — Pending Jan 13, 2023
18070887 FLOW CELLS AND METHODS OF USE THEREOF 10X Genomics, Inc. KASS, BENJAMIN JOSEPH 1682 §102§103§112 Non-Final OA — Pending Nov 29, 2022

Managing Clark+Elbing LLP - 10X Genomics, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Clark+Elbing LLP - 10X Genomics, Inc.'s patent allowance rate?

67.8% of resolved applications prosecuted by Clark+Elbing LLP - 10X Genomics, Inc. were allowed, across 9,010 applications in USPTO records.

How many office actions does Clark+Elbing LLP - 10X Genomics, Inc. average before allowance?

3.89 office actions per allowed application on average.

How many pending office actions does Clark+Elbing LLP - 10X Genomics, Inc. have?

10 pending office actions as of October 2026, for 1 client, before 10 examiners in 7 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month